Phase I epithelial lining study of ceftolozane/tazobactam.

Trial Profile

Phase I epithelial lining study of ceftolozane/tazobactam.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Jul 2012

At a glance

  • Drugs Ceftolozane/tazobactam (Primary) ; Piperacillin/tazobactam (Primary)
  • Indications Gram-negative infections; Nosocomial pneumonia; Pseudomonal infections; Respiratory tract infections
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 23 Oct 2011 Results presented at the 49th Annual Meeting of the Infectious Diseases Society of America.
    • 16 Jun 2011 Status changed from recruiting to completed based on information reported in a Cubist Pharmaceuticals media release.
    • 16 Jun 2011 Results have been reported in a Cubist Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top